Donna Senger

Dr. Senger obtained her PhD in the Department of Cell Biology at the University of Alberta. During her Ph. D studies she published a seminal paper in her field that described a novel signaling process in sympathetic neurons where nerve growth factor (NGF) induces a rapidly propagated signal that does not require vesicular transport of NGF. In 2000, Dr. Senger moved to the University of Calgary where she helped to establish a multi-disciplinary translational research group. Dr. Senger’s research has focused on numerous aspects of both primary and metastatic brain cancer with an emphasis on understanding brain tumour progression for the development of new treatments.